Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Newbury Pharmaceuticals AB | 11,121,714 | net | 18 Nov 2025 | tx 12+11,121,714 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Nov 2025 | PURCHASE | Newbury Pharmaceuticals AB | 25,859 | 1.59 SEK | |
| 17 Nov 2025 | PURCHASE | Newbury Pharmaceuticals AB | 67,855 | 1.39 SEK | |
| 12 Nov 2025 | PURCHASE | Newbury Pharmaceuticals AB | 20,000 | 1.91 SEK | first after silence |
| 08 Apr 2024 | LENDING | Newbury Pharmaceuticals AB | 612,500 | 0.00 SEK | |
| 04 Mar 2024 | LENDING | Newbury Pharmaceuticals AB | 612,500 | 0.00 SEK | |
| 25 Jan 2024 | PURCHASE | Newbury Pharmaceuticals AB | 7,000 | 4.78 SEK | |
| 23 Jan 2024 | PURCHASE | Newbury Pharmaceuticals AB | 4,000 | 4.84 SEK | |
| 22 Jan 2024 | PURCHASE | Newbury Pharmaceuticals AB | 4,000 | 4.73 SEK | |
| 16 Jan 2024 | PURCHASE | Newbury Pharmaceuticals AB | 6,000 | 3.75 SEK | |
| 12 Jan 2024 | PURCHASE | Newbury Pharmaceuticals AB | 7,000 | 3.84 SEK | |
| 11 Jan 2024 | PURCHASE | Newbury Pharmaceuticals AB | 9,750,000 | 0.36 SEK | anomaly |
| 12 Apr 2023 | PURCHASE | Newbury Pharmaceuticals AB | 5,000 | 5.28 SEK |
1 purchase reported after at least 12 months of silence — most recent on 12 Nov 2025.